SCHEDULE 13D/A 0001363391 XXXXXXXX LIVE 13 Class I common shares of beneficial interest 10/30/2025 false 0001940499 48130F306 JPMorgan Private Markets Fund

277 Park Avenue New York NY 10172

Tyler Jayroe 212-270-6000 c/o J.P. Morgan Invest. Mgmt. Inc. 277 Park Ave New York NY 10172 0001363391 N J.P. Morgan Investment Management Inc. WC N DE 3033788.02 3033788.02 3033788.02 N 8.1 IA CO Class I common shares of beneficial interest JPMorgan Private Markets Fund 277 Park Avenue New York NY 10172 Explanatory Note This Amendment No. 13 to Schedule 13D ("Amendment No. 13") is being filed by J.P. Morgan Investment Management Inc. ("JPMIM" or the "Reporting Person") and amends and supplements the statement on Schedule 13D originally filed with the Securities and Exchange Commission on July 24, 2023, as amended by Amendment No. 1 filed with the Securities and Exchange Commission on September 20, 2023, as amended by Amendment No. 2 filed with the Securities and Exchange Commission on December 22, 2023, as amended by Amendment No. 3 filed with the Securities and Exchange Commission on March 21, 2024, as amended by Amendment No. 4 filed with the Securities and Exchange Commission on April 23, 2024, as amended by Amendment No. 5 filed with the Securities and Exchange Commission on July 2, 2024, as amended by Amendment No. 6 filed with the Securities and Exchange Commission on August 30, 2024; as amended by Amendment No. 7 filed with the Securities and Exchange Commission on October 31, 2024; as amended by Amendment No. 8 filed with the Securities and Exchange Commission on December 31, 2024; as amended by Amendment No. 9 filed with the Securities and Exchange Commission on March 4, 2025; as amended by Amendment No. 10 filed with the Securities and Exchange Commission on May 2, 2025; as amended by Amendment No. 11 filed with the Securities and Exchange Commission on July 2, 2025; as amended by Amendment No. 12 filed with the Securities and Exchange Commission on October 2, 2025 (as amended, the "Schedule 13D") related to the Class I common shares of beneficial interest (the "Class I Common Shares") of JPMorgan Private Markets Fund, a Delaware statutory trust (the "Issuer"). The Items below amend the information disclosed under the corresponding Items of the Schedule 13D as described below. Except as specifically provided herein, this Amendment No. 13 does not modify any of the information previously reported in the Schedule 13D. Capitalized terms used herein without definition shall have the meaning set forth in the Schedule 13D. Item 2 of this Schedule 13D is being amended and supplemented to include an updated Annex A attached hereto as Exhibit 99.1. Item 4 of the Schedule 13D is hereby amended and supplemented to include the following: On October 1, 2025, Reporting Person's agreement to tender Class I Common Shares to the Issuer was accepted. On October 30, 2025, the number of shares being sold by the Reporting Person was fixed when the price per share was determined by the Issuer, following the determination of the Issuer's net asset value as of September 30, 2025. Specifically, the Issuer repurchased 1,152,472.05 shares from JPMIM pursuant to the tender offer for an aggregate sales price of approximately $20,000,000 or $17.3540 per Class I Common Share. The repurchase closed on October 30, 2025. Item 5(a) of this Schedule 13D is hereby amended and restated as follows: The information set forth in the cover pages of this Schedule 13D is hereby incorporated by reference into this Item 5. As of the date hereof, JPMIM may be deemed to beneficially own an aggregate of 3,033,788.021 Class I Common Shares representing approximately 8.13% of the outstanding Class I Common Shares. The percentage of beneficial ownership in this Schedule 13D assumes that there are 37,319,431.595 Class I Common Shares outstanding as of the date hereof based on information received from the Issuer. Exhibit 99.1 Annex A J.P. Morgan Investment Management Inc. /s/ Tyler Jayroe 11/03/2025